Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).

Lu F, Wikramasinghe P, Norseen J, Tsai K, Wang P, Showe L, Davuluri RV, Lieberman PM.

Virol J. 2010 Oct 7;7:262. doi: 10.1186/1743-422X-7-262.

2.

Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, Showe L, Lu F, Wikramasinghe P, Lieberman PM.

J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15. Print 2016 Jan 1.

3.

HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.

Dheekollu J, Wiedmer A, Sentana-Lledo D, Cassel J, Messick T, Lieberman PM.

J Virol. 2016 May 12;90(11):5353-5367. doi: 10.1128/JVI.00239-16. Print 2016 Jun 1.

4.

DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.

Yasuda A, Noguchi K, Minoshima M, Kashiwazaki G, Kanda T, Katayama K, Mitsuhashi J, Bando T, Sugiyama H, Sugimoto Y.

Cancer Sci. 2011 Dec;102(12):2221-30. doi: 10.1111/j.1349-7006.2011.02098.x. Epub 2011 Sep 30.

5.

Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.

Lee EK, Kim SY, Noh KW, Joo EH, Zhao B, Kieff E, Kang MS.

Antiviral Res. 2014 Apr;104:73-83. doi: 10.1016/j.antiviral.2014.01.018. Epub 2014 Jan 31.

6.

Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.

Deakyne JS, Malecka KA, Messick TE, Lieberman PM.

J Virol. 2017 Sep 12;91(19). pii: e01046-17. doi: 10.1128/JVI.01046-17. Print 2017 Oct 1.

7.

Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1.

Tempera I, Deng Z, Atanasiu C, Chen CJ, D'Erme M, Lieberman PM.

J Virol. 2010 May;84(10):4988-97. doi: 10.1128/JVI.02333-09. Epub 2010 Mar 10.

8.

Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.

Shen CL, Liu CD, You RI, Ching YH, Liang J, Ke L, Chen YL, Chen HC, Hsu HJ, Liou JW, Kieff E, Peng CW.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2229-34. doi: 10.1073/pnas.1525444113. Epub 2016 Feb 8.

9.

E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.

Boreström C, Forsman A, Rüetschi U, Rymo L.

J Gen Virol. 2012 May;93(Pt 5):1065-75. doi: 10.1099/vir.0.038752-0. Epub 2012 Feb 1.

PMID:
22302879
10.

Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance.

Kanda T, Horikoshi N, Murata T, Kawashima D, Sugimoto A, Narita Y, Kurumizaka H, Tsurumi T.

J Biol Chem. 2013 Aug 16;288(33):24189-99. doi: 10.1074/jbc.M113.491167. Epub 2013 Jul 8.

11.

EBNA1 regulates cellular gene expression by binding cellular promoters.

Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM.

Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22421-6. doi: 10.1073/pnas.0911676106. Epub 2009 Dec 22.

12.

Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.

Hodin TL, Najrana T, Yates JL.

J Virol. 2013 Dec;87(23):13020-8. doi: 10.1128/JVI.01606-13. Epub 2013 Sep 25.

13.

In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.

Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Tsurumi T.

J Biol Chem. 2004 Dec 24;279(52):54817-25. Epub 2004 Oct 21.

14.
16.
17.

EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.

Sarkari F, Sanchez-Alcaraz T, Wang S, Holowaty MN, Sheng Y, Frappier L.

PLoS Pathog. 2009 Oct;5(10):e1000624. doi: 10.1371/journal.ppat.1000624. Epub 2009 Oct 16.

18.

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM.

Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.

19.
20.

Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment.

Norseen J, Johnson FB, Lieberman PM.

J Virol. 2009 Oct;83(20):10336-46. doi: 10.1128/JVI.00747-09. Epub 2009 Aug 5.

Supplemental Content

Support Center